Endologix

Surmodics is a global leader in surface modification technologies, specializing in innovative solutions for intravascular medical devices. With a rich history dating back to the development of the first drug-eluting stent, Surmodics excels in creating advanced drug-delivery coatings known for their lubricious and hemocompatible properties. The company goes beyond coatings to deliver comprehensive whole-product solutions, including sophisticated balloon catheter design and manufacturing. Surmodics also stands out in the field of in vitro diagnostics (IVD), offering chemical components for immunoassay tests and microarrays.

Among the company’s notable offerings is the Pounce™ Thrombectomy System, designed to meet critical clinical needs with precision-engineered technology. Surmodics prioritizes collaboration with clients to expedite the process of bringing new products from concept to successful market launch. Additionally, the company serves as a vital link between the biotech and medical device industries, enabling the development of unique drug/device combination products. With locations in the USA and Ireland, Surmodics continues to redefine the standards in healthcare innovation.